Particularly, syndecan-1 (CD138), frequently expressed in epithelial cells and some leukocytes [155], was found to be increased in bladder cancer patients serum and stroma, especially in muscle-invasive cases [156-158]. Here, SDC1 is linked to urinary bladder cancer.